==== 0:00 Intro 3:16 Treating Aging as a Disease 12:16 Launching a Radical Biotech Company 15:49 Why Telomere Length Mattered Most 18:51 Fear at the Edge of Experimentation 24:19 Ad: Optoceutics 26:08 Alpha-Klotho, The Longevity Gene 30:02 Why Alzheimers Still Has No Cure 32:21 Mitochondria at the Center of Brain Health 36:04 Ad: Fresh Pressed Olive Oil Club 39:04 Keeping PGC-1 Alpha Switched On 42:43 Tracking Telomere Length Year After Year 47:11 Ad: 3x4 Genetics 48:37 Myokines and Whole-Body Health 51:48 Glutathione Deficiency and Neurodegeneration 1:00:20 Closing Thoughts ==== Elizabeth (Liz) Parrish, MBA, is the Founder and CEO of BioViva Sciences USA Inc., a pioneering biotechnology company committed to extending healthy human lifespan through advanced gene therapies
Chiu DN, Jahr CE
The DRI modification makes the peptide backbone unrecognizable to endogenous aminopeptidases, carboxypeptidases, and endopeptidases, extending functional persistence from minutes to an estimated hours-to-days range
Ngoi ra, vitamin C cn gip cc t bo bch cu lympho hot ng hiu qu chng li s xm nhp ca vi khun c th gy ra nhim trng vt thng
Since the human organism lacks the enzyme necessary for vitamin C synthesis, i.e., L-glucono-gamma-lactone-oxidase, it needs to be provided with food [50]
